AYOXXA Signs Research Agreement in the Field of Ophthalmology With One of the Leading Pharmaceutical Companies Read more: https://www.digitaljournal.com/pr/4096501#ixzz5c2jn0g5c

Agreement targets the development of low volume and high sensitivity multiplex assays for aqueous humor protein profiling for biomarker identification and validation in support of drug discovery in ophthalmology This collaboration reflects an initial phase of a multi study plan in the field of ophthalmology Further step to establish AYOXXA LUNARISTM system as the standard for [...]

Color to Move Whole Genome Sequencing Into Clinical Care through 100,000-Person Initiative Focused on Polygenic Risk

SAN FRANCISCO -- Today Color announced an initiative to help build the foundation for the first mainstream application of whole genome sequencing in clinical care, through the use of polygenic risk scores. Polygenic risk scoring can help clinicians identify populations who are at risk for diseases such as cancer and heart disease in order to optimize prevention [...]

NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018

— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance — — Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the fourth quarter and fiscal [...]

Paragon Genomics Partners with MGI Tech to Distribute its CleanPlex® NGS Target Enrichment Panels Worldwide

 –Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.– –Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution– HAYWARD, CA – Paragon Genomics, Inc., a [...]

PierianDx Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics

Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis ST. LOUIS--PierianDx, a leading clinical genomics informatics company, today announced a strategic, non-exclusive, multi-year partnership with Illumina, Inc. to provide a variant interpretation and reporting solution based on PierianDx’s Clinical Genomics [...]

OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance

CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics Novosanis’ urine collection technology expands molecular collection portfolio and advances OraSure’s expertise in non-invasive sampling BETHLEHEM, Pa. -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today [...]

Barben Analytical Launches OXYvisor™ Next-Generation Process Oxygen Analyzer

CARSON CITY, NV – Barben Analytical, a leader in pH/ORP, oxygen and conductivity measurement products, has introduced OXYvisor, its second-generation process oxygen analyzer, which optically measures oxygen in either the gas or liquid phase. In terms of performance, OXYvisor has no equal in the marketplace for trace level ppm O2 gas phase measurements.  In the gas [...]

Climate Protection Certificate for Elementar

100% green electricity - another contribution to environmental protection The new year starts with good news: since January 1st, 2019 Elementar Analysensysteme GmbH covers 100% of its demand for electricity from certified, renewable energy. This is obtained entirely from ecological energy sources and thus protects the environment. This saves CO2 emissions of 388.42 tonnes annually. For [...]

Schrödinger Closes $85 Million Financing to Advance Computational Platform and Expand Drug Discovery Pipeline

Investment in R&D will extend capabilities of computational platform and support growth of partnered and proprietary programs NEW YORK – Schrödinger, a privately held company revolutionizing drug discovery through advanced molecular simulations, today announced the closing of an $85 million financing to support continued growth and innovation of its computational platform and expansion of its [...]

SOPHIA GENETICS RAISES $77 MILLION TO ACCELERATE THE DEMOCRATIZATION OF DATA-DRIVEN MEDICINE

San Francisco, Jan. 4, 2019: SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data- Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, [...]

Access IBO on Knowledge Center